Market Tracker

09/01 6:59am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

32.58
Data as of Aug 29
 +0.29 / +0.90%
Today’s Change
27.51
Today|||52-Week Range
39.95
+11.58%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close32.29
Today’s open32.30
Day’s range32.05 - 32.87
Volume142,812
Average volume (3 months)553,582
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-33.21%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio72.4
Price/Sales3.49
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc-0.05-0.10%
LCILannett Company Inc+0.57+1.47%
CBPOChina Biologic Produ...-0.65-1.21%
NBIXNeurocrine Bioscienc...+0.32+2.00%
Data as of 4:01pm ET, 08/29/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts